Literature DB >> 11462000

Genetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber.

M K Magnusson1, S S Hong, P Boulanger, L Lindholm.   

Abstract

For efficient and versatile use of adenovirus (Ad) as an in vivo gene therapy vector, modulation of the viral tropism is highly desirable. In this study, a novel method to genetically alter the Ad fiber tropism is described. The knob and the last 15 shaft repeats of the fiber gene were deleted and replaced with an external trimerization motif and a new cell-binding ligand, in this case the integrin-binding motif RGD. The corresponding recombinant fiber retained the basic biological functions of the natural fiber, i.e., trimerization, nuclear import, penton formation, and ligand binding. The recombinant fiber bound to integrins but failed to react with antiknob antibody. For virus production, the recombinant fiber gene was rescued into the Ad genome at the exact position of the wild-type (WT) fiber to make use of the native regulation of fiber expression. The recombinant virus Ad5/FibR7-RGD yielded plaques on 293 cells, but the spread through the monolayer was two to three times delayed compared to WT, and the ratio of infectious to physical particles was 20 times lower. Studies on virus tropism showed that Ad5/FibR7-RGD was able to infect cells which did not express the coxsackie-adenovirus receptor (CAR), but did express integrins. Ad5/FibR7-RGD virus infectivity was unchanged in the presence of antiknob antibody, which neutralized the WT virus. Ad5/FibR7-RGD virus showed an expanded tropism, which is useful when gene transfer to cells not expressing CAR is needed. The described method should also make possible the construction of Ad genetically retargeted via ligands other than RGD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462000      PMCID: PMC114963          DOI: 10.1128/JVI.75.16.7280-7289.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR.

Authors:  G Santis; V Legrand; S S Hong; E Davison; I Kirby; J L Imler; R W Finberg; J M Bergelson; M Mehtali; P Boulanger
Journal:  J Gen Virol       Date:  1999-06       Impact factor: 3.891

2.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Targeted gene delivery by tropism-modified adenoviral vectors.

Authors:  J T Douglas; B E Rogers; M E Rosenfeld; S I Michael; M Feng; D T Curiel
Journal:  Nat Biotechnol       Date:  1996-11       Impact factor: 54.908

4.  Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.

Authors:  V Legrand; D Spehner; Y Schlesinger; N Settelen; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.

Authors:  I Huvent; S S Hong; C Fournier; B Gay; J Tournier; C Carrière; M Courcoul; R Vigne; B Spire; P Boulanger
Journal:  J Gen Virol       Date:  1998-05       Impact factor: 3.891

6.  RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection.

Authors:  E Vigne; I Mahfouz; J F Dedieu; A Brie; M Perricaudet; P Yeh
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity.

Authors:  S S Hong; A Galaup; R Peytavi; N Chazal; P Boulanger
Journal:  Hum Gene Ther       Date:  1999-11-01       Impact factor: 5.695

8.  A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles.

Authors:  D J Von Seggern; C Y Chiu; S K Fleck; P L Stewart; G R Nemerow
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Authors:  I Dmitriev; V Krasnykh; C R Miller; M Wang; E Kashentseva; G Mikheeva; N Belousova; D T Curiel
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR.

Authors:  I Kirby; E Davison; A J Beavil; C P Soh; T J Wickham; P W Roelvink; I Kovesdi; B J Sutton; G Santis
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

View more
  29 in total

Review 1.  Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.

Authors:  Vincent Hurez; Robin D Hautton; James Oliver; R James Matthews; Casey K Weaver
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Metabolic biotinylation of recombinant proteins in mammalian cells and in mice.

Authors:  M B Parrott; M A Barry
Journal:  Mol Ther       Date:  2000-01       Impact factor: 11.454

3.  Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein.

Authors:  Natalya Belousova; Valentina Krendelchtchikova; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.

Authors:  Ijad Madisch; Gabi Harste; Heidi Pommer; Albert Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 5.  Transductional targeting of adenovirus vectors for gene therapy.

Authors:  J N Glasgow; M Everts; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-27       Impact factor: 5.987

6.  Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.

Authors:  L Pereboeva; S Komarova; J Roth; S Ponnazhagan; D T Curiel
Journal:  Gene Ther       Date:  2007-01-25       Impact factor: 5.250

Review 7.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

8.  The effect of fiber truncations on the stability of adenovirus type 5.

Authors:  Grit Kupgan; Danielle C Hentges; Nathan J Muschinske; William D Picking; Wendy L Picking; Joshua D Ramsey
Journal:  Mol Biotechnol       Date:  2014-11       Impact factor: 2.695

9.  Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein.

Authors:  Sayuri E Kato; Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  Genetically targeted adenovirus vector directed to CD40-expressing cells.

Authors:  Natalya Belousova; Nikolay Korokhov; Valentina Krendelshchikova; Vera Simonenko; Galina Mikheeva; Pierre L Triozzi; Wayne A Aldrich; Papia T Banerjee; Stephen D Gillies; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.